Clear-cell carcinoma of the ovary

被引:77
作者
Fujiwara, K. [1 ]
Shintani, D. [1 ]
Nishikawa, T. [1 ]
机构
[1] Saitama Med Univ, Int Med Ctr, Dept Gynecol Oncol, Hidaka City, Japan
关键词
GYNECOLOGIC-ONCOLOGY-GROUP; ADJUVANT CHEMOTHERAPY; CANCER; ADENOCARCINOMA; IDENTIFICATION; CISPLATIN; TARGET; JAPAN;
D O I
10.1093/annonc/mdw086
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Clear-cell carcinoma of the ovary (CCCO) is a distinct entity of epithelial ovarian cancer in terms of clinical, histopathological, or genetic features. The incidence of CCCO is different by ethnicity but the reason is not clear yet. Overall prognosis of CCCO is good because most CCCO is found in stage I. However, advanced disease is associated with a very poor prognosis and resistance to standard treatment. The same is true for recurrent disease. Therefore, genetic analysis of CCCO is important to find the right target(s) and better therapeutic approaches. Because of its rarity, international collaboration is necessary to conduct randomized clinical trials for CCCO.
引用
收藏
页码:50 / 52
页数:3
相关论文
共 18 条
[1]   Clear cell carcinoma of the ovary: A report from the first Ovarian Clear Cell Symposium, June 24th, 2010 [J].
Anglesio, Michael S. ;
Carey, Mark S. ;
Koebel, Martin ;
MacKay, Helen ;
Huntsman, David G. .
GYNECOLOGIC ONCOLOGY, 2011, 121 (02) :407-415
[2]   Low-Stage Ovarian Clear Cell Carcinoma: Population-Based Outcomes in British Columbia, Canada, With Evidence for a Survival Benefit As a Result of Irradiation [J].
Hoskins, Paul J. ;
Le, Nhu ;
Gilks, Blake ;
Tinker, Anna ;
Santos, Jennifer ;
Wong, Frances ;
Swenerton, Kenneth D. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (14) :1656-1662
[3]   WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma [J].
Kaneuchi, M ;
Sasaki, M ;
Tanaka, Y ;
Shiina, H ;
Yamada, H ;
Yamamoto, R ;
Sakuragi, N ;
Enokida, H ;
Verma, M ;
Dahiya, R .
CANCER, 2005, 104 (09) :1924-1930
[4]   Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial [J].
Katsumata, Noriyuki ;
Yasuda, Makoto ;
Takahashi, Fumiaki ;
Isonishi, Seiji ;
Jobo, Toshiko ;
Aoki, Doisuke ;
Tsuda, Hiroshi ;
Sugiyama, Toru ;
Kodama, Shoji ;
Kimura, Eizo ;
Ochiai, Kazunori ;
Noda, Kiichiro .
LANCET, 2009, 374 (9698) :1331-1338
[5]   Risk of developing ovarian cancer among women with ovarian endometrioma: a cohort study in Shizuoka, Japan [J].
Kobayashi, H. ;
Sumimoto, K. ;
Moniwa, N. ;
Imai, M. ;
Takakura, K. ;
Kuromaki, T. ;
Morioka, E. ;
Arisawa, K. ;
Terao, T. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2007, 17 (01) :37-43
[6]   mTOR Is a Promising Therapeutic Target Both in Cisplatin-Sensitive and Cisplatin-Resistant Clear Cell Carcinoma of the Ovary [J].
Mabuchi, Seiji ;
Kawase, Chiaki ;
Altomare, Deborah A. ;
Morishige, Kenichirou ;
Sawada, Kenjiro ;
Hayashi, Masami ;
Tsujimoto, Masahiko ;
Yamoto, Mareo ;
Klein-Szanto, Andres J. ;
Schilder, Russell J. ;
Ohmichi, Masahide ;
Testa, Joseph R. ;
Kimura, Tadashi .
CLINICAL CANCER RESEARCH, 2009, 15 (17) :5404-5413
[7]   Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study. [J].
Okamoto, Aikou ;
Sugiyama, Toru ;
Hamano, Tetsutaro ;
Kim, Jae Weon ;
Kim, Byoung Gie ;
Enomoto, Takayuki ;
Aoki, Daisuke ;
Terao, Yasuhisa ;
Suzuki, Nao ;
Mikami, Mikio ;
Yaegashi, Nobuo ;
Kato, Kiyoko ;
Yoshikawa, Hiroyuki ;
Pignata, Sandro ;
Alexandre, Jerome ;
Green, John A. ;
Isonishi, Seiji ;
Terauchi, Fumitoshi ;
Fujiwara, Keiichi ;
Ochiai, Kazunori .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[8]   Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Ovary [J].
Okamoto, Aikou ;
Glasspool, Rosalind M. ;
Mabuchi, Seiji ;
Matsumura, Noriomi ;
Nomura, Hiroyuki ;
Itamochi, Hiroaki ;
Takano, Masashi ;
Takano, Tadao ;
Susumu, Nobuyuki ;
Aoki, Daisuke ;
Konishi, Ikuo ;
Covens, Alan ;
Ledermann, Jonathan ;
Mezzazanica, Delia ;
Steer, Christopher ;
Millan, David ;
McNeish, Iain A. ;
Pfisterer, Jacobus ;
Kang, Sokbom ;
Gladieff, Laurence ;
Bryce, Jane ;
Oza, Amit .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) :S20-S25
[9]  
Sato N, 2000, CANCER RES, V60, P7052
[10]  
Sekizawa Akihiko, 2004, Medical Electron Microscopy, V37, P97